Extended-schedule dose-dense temozolomide in refractory gliomas

This multicenter phase II study conducted by the Spanish Neuro-Oncology Group evaluated the activity of an extended, dose-dense temozolomide regimen in patients with temozolomide-refractory malignant glioma. Adult patients (at least 18 years of age) with WHO grade III or IV glioma and a Karnofsky Pe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Berrocal, A., Perez Segura, P., Gil, M., Balaña, C., Garcia Lopez, J., Yaya, R., Rodríguez, J., Reynes, G., Gallego, O., Iglesias, L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2009
Soggetti:
Clinical Study - Patient Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2808507/
https://ncbi.nlm.nih.gov/pubmed/19669096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9980-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi